谷歌浏览器插件
订阅小程序
在清言上使用

Updated Results of a Phase I/II Prospective Dose Escalation Trial Evaluating Safety and Efficacy of Combination 177lu PSMA 617 and Idronoxil in Men with Mcrpc Post Androgen Signalling Inhibition and Taxane Chemotherapy (lupin Trial).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 3|浏览13
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要